Enpirin Capsule 75 mg (Pregabalin)

Adult dose

This medication should be taken orally in divided doses of the total daily dose, twice a day, regardless of meals. 1. Neuropathic pain - Peripheral neuropathic pain: Initial dose is 150 mg per day, increased to 300 mg per day after 3 to 7 days, with the possibility of increasing up to 600 mg after 7-day intervals as needed. - Central neuropathic pain: Initial dose is 150 mg per day, increased to 300 mg per day after 1 week.

Child dose

The safety and efficacy data for children under 12 years old and adolescents aged 12 to 17 are insufficient; therefore, administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so mood or behavior changes must be closely monitored during treatment. Patients with allergies to pregabalin or any component of this medication, or those with certain genetic lactose-related disorders, should not take this medication. Diabetic patients should be cautious as weight gain may necessitate dosage adjustments of blood sugar control medications. If symptoms of angioedema occur, discontinue the medication immediately and consult with a healthcare professional. Older adults should be especially careful during initial treatment due to the increased risk of falls from side effects such as dizziness and drowsiness. Blurry vision or changes in vision may occur; these symptoms may improve after discontinuation of the medication. Suddenly stopping this medication after long-term use may lead to withdrawal symptoms such as insomnia, headache, and anxiety. Patients with a history of substance abuse should be careful with potential misuse or dependence on this medication. Patients with impaired kidney function may require dosage adjustments. Patients with heart disease should also use caution when taking this medication. There is a risk of central nervous system depression when taken with opioid analgesics, so caution is advised. Patients with respiratory diseases, kidney disorders, or the elderly are at risk of severe respiratory depression, necessitating potential dosage adjustments. In early pregnancy, there may be a risk of fetal malformation, so use should be avoided, and women of childbearing potential should use effective contraception. Lactating women should consult their physician as this medication may be passed into breast milk, and nursing should be discontinued. When engaging in hazardous activities such as driving or operating machinery, caution is needed due to dizziness and drowsiness. Severe skin reactions may occur; monitor skin condition carefully and discontinue immediately if abnormalities arise. In cases of overdose, symptoms such as drowsiness, confusion, and depression may occur, and treatments such as blood dialysis may be required if necessary. Special caution is needed for children, the elderly, and patients with impaired kidney function, and storage should be out of reach of children.

Serious side effects

• Hives
• severe swelling (angioedema)
• chest tightness
• difficulty breathing
• cold sweat
• pallor
• severe rash with fever
• blisters
• skin peeling
• pain in mouth/eye mucous membranes

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• feelings of euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to protect it from exposure to air or moisture, at a temperature between 15 to 30 degrees Celsius. Storing in this manner will help maintain the effectiveness of the medication for a longer period.

Appearance

A hard capsule with a reddish-brown upper part and a white lower part containing white powder that is white or light yellow in color.

Package unit

30 capsules/bottle, 200 capsules/bottle